Xiaoyue Cui

482 citations
9 papers · 368 indexed · 1 hit paper · h-index 7
Topics
CAR-T cell therapy research (3 papers)Immune Cell Function and Interaction (3 papers)T-cell and B-cell Immunology (2 papers)

In The Last Decade

Xiaoyue Cui

9 papers receiving 366 citations

Hit Papers

NKG2D-CAR T cells eliminate senescent cells in aged mice ...20232026202420252023255075100

Peers

Xiaoyue Cui
Comparison fields: 5 of 69
  • Oncology 157
  • Immunology 137
  • Molecular Biology 128
  • Physiology 70
  • Epidemiology 43
Replace Baokun He with:
Baokun He China
Kathryn Gilroy United Kingdom
Lori Patnaude United States
Ece Yıldız Switzerland
Zhitao Gao China
Yusuke Shimizu Japan
Fengyan Deng United States
Jingxiang Zhong China
Juliette Paillet France
Thinh Chau United States
Xiaoyue Cui relative to Baokun He China Baokun He's profile →
Citations per field
00.5×3.3×
Baokun He · 1×
Citations per year

Countries citing papers authored by Xiaoyue Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaoyue Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyue Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyue Cui more than expected).

Fields of papers citing papers by Xiaoyue Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyue Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyue Cui. The network helps show where Xiaoyue Cui may publish in the future.

Co-authorship network of co-authors of Xiaoyue Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyue Cui. A scholar is included among the top collaborators of Xiaoyue Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyue Cui. Xiaoyue Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1
NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primatesbreakdown →
114
2 2
3 1
4 9
5 62
6 27
7 32
8 115
9 6

About Xiaoyue Cui

Xiaoyue Cui is a scholar working on Complementary and alternative medicine, Oncology and Immunology, having authored 9 papers that have together received 368 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (3 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Aging (12 citations), Immunology (137 citations) and Oncology (157 citations). Xiaoyue Cui has collaborated with scholars based in China, South Korea and Bangladesh. Frequent co-authors include Xudong Zhao, Bin Sun, Dong Yang, Xiuyun Liu, Xianning Zhang, Hongjiu Dai, Ru Jia, Changchun Cai, Wenxuan Li and Jianming Xu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Science Translational Medicine and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026